~~<i id='43CF433153'><strike id='43CF433153'><tt id='43CF433153'><pre id='43CF433153'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

focus

author：focus 2025-09-03 09:25:17 - browse：496

LONDON — GSK said Tuesday it would purchase the asthma-focused drug developer Aiolos Bio for $1 billion upfront, the latest in a string of pharma acquisitions that are bolstering hopes for the industry’s year ahead.

The deal includes up to another $400 million in payments if certain milestones are met.

Aiolos was launched just last year, based in both San Francisco and London. The company, which announced a $245 million Series A round in October, has been readying a Phase 2 trial of its candidate AIO-001 in adult asthma.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

entertainment

hotspot

knowledge

focus

Wikipedia

knowledge

CTbrainofapatientwithtraumaticbraininjuryshowingsubarachnoidhemorrhage.AdobeTraumaticbraininjury,lon

WSS

FDA endorses new sterilization method for medical devices

Inaction leaves children at risk from dangerous chemotherapy drug

PhRMA sues HHS over Medicare drug price negotiation

Medicare drug price lawsuits could be good politics for Biden

Pfizer's Covid pill remains 89% effective in final analysis, company says

These geoengineering technologies could help combat the climate crisis, scientists say

leisure time

focus

entertainment

Medical leaders decry Supreme Court decision on affirmative action

Maisha Meds is a PBM, but don't call it that

DIEP, the 'gold standard' of breast reconstruction, is under threat

When is a doctor not a doctor? Try when patients address women doctors

Continuity nursing helped my family in our darkest PICU moments

Did the public have the right to know Arthur Ashe had AIDS?

Affirmative action in medical school literally saved lives

Flu vaccine reformulation won't be easy, manufacturers warn

Peter Hotez and the public health issue of online harassment

7 people shot in DC, police say

hotspot

Brain 'hot spot' may explain why African Americans feel greater pain

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

Update the Apgar Score to remove skin color

Van's Gluten Free Original Waffles recalled for possible wheat allergen

These geoengineering technologies could help combat the climate crisis, scientists say

PhRMA sues HHS over Medicare drug price negotiation

knowledge

focus

Wikipedia

knowledge